Visual Podcast: FDA/Xavier Joint Initiative Aims To Help Device Firms Predict Quality Metrics
This article was originally published in The Gray Sheet
Executive Summary
In a second Gray Sheet educational podcast, Xavier University's Marla Phillips explains a partnership between FDA and the school on a metrics initiative to identify, pilot, plan and publicize predictive quality system metrics. "We're looking at … developing a system of metrics across the total product lifecycle. In doing that, it enables companies to assess and improve the robustness of their critical-to-quality practices and, therefore, risk to product quality," she says.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.